TCL Archive FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe December 5, 1986
TCL Archive Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years May 9, 1997
TCL Archive Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs August 2, 2002
